摘要
背景:以往的研究表明,血浆性激素可能与阿尔茨海默病(阿尔茨海默病)的发病有关。然而,性激素和AD之间的关系仍不清楚。目的:系统评价和定量分析研究,观察血浆总睾酮(TT)、雌二醇(E2)、性激素结合球蛋白(SHBG)在AD患者中的水平。方法:检索MEDLINE、EMBASE、Cochrane图书馆,和PsycINFO®搜索2014年3月28日之前发表的研究。发表的研究报道,血浆TT、E2水平,和在AD中的性激素结合球蛋白和匹配控制纳入荟萃分析。结果:采用随机效应模型进行荟萃分析,连续表达结果作为AD与控制群体间的平均差异。95%置信区间(次)进行了计算。血浆中睾酮与雌二醇的AD和对照组之间的水平没有差异(TT MD -0.17 nmol/l, 95%CI -0.54, 0.20; E2 MD -1.16 pmol/l, 95%CI -9.85, 6.83)。与健康对照组相比,AD患者血浆性激素结合球蛋白水平显著提高(SHBG MD 12.94 nmol/l, 95%CI 2.68, 23.20)。结论:AD患者存在血浆SHBG水平较高的情况。血浆SHBG的上调显示初步支持性证据,SHBG与血浆中功能性激素的生物利用度可能与AD的发病机制有关。
关键词: 阿尔茨海默氏病,生物标志物,雌二醇,荟萃分析,性激素结合球蛋白,睾酮。
Current Alzheimer Research
Title:Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer’s Disease: A Meta-Analysis
Volume: 13 Issue: 3
Author(s): Jing Xu, Lei-Lei Xia, Ning Song, Sheng-Di Chen, Gang Wang
Affiliation:
关键词: 阿尔茨海默氏病,生物标志物,雌二醇,荟萃分析,性激素结合球蛋白,睾酮。
摘要: Background: Previous studies suggested that plasma sex hormones may be implicated in the pathogenesis of Alzheimer’s disease (AD). However, the relationship between sex hormones and AD remains unclear. Objective: To systematically review and quantitatively analyze studies observing plasma total testosterone (TT), estradiol (E2), and sex hormone-binding globulin (SHBG) levels among AD patients. Methods: Medline, EMBASE, the Cochrane Library, and PsycINFO® were searched for studies published prior to March 28th, 2014. Published studies that reported plasma levels of TT, E2, and SHBG in AD and matched controls were included in the present meta-analysis. Results: Meta-analysis was performed using the random effects model, expressing continuous outcomes as the mean difference (MD) between AD and control populations. The 95% confidence intervals (CI) were also calculated. No differences were found in plasma levels of TT and E2 between AD and matched controls (TT MD -0.17 nmol/l, 95%CI -0.54, 0.20; E2 MD -1.16 pmol/l, 95%CI -9.85, 6.83). Plasma levels of SHBG were significantly increased in AD patients compared to healthy controls (SHBG MD 12.94 nmol/l, 95%CI 2.68, 23.20). Conclusion: Patients with AD had higher plasma levels of SHBG. The up-regulated levels of plasma SHBG show preliminary supportive evidence that SHBG and the bioavailability of functional sex hormones in plasma may be linked to the pathogenesis of AD.
Export Options
About this article
Cite this article as:
Jing Xu, Lei-Lei Xia, Ning Song, Sheng-Di Chen, Gang Wang , Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer’s Disease: A Meta-Analysis, Current Alzheimer Research 2016; 13 (3) . https://dx.doi.org/10.2174/1567205013666151218145752
DOI https://dx.doi.org/10.2174/1567205013666151218145752 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design Implementation of Cardiovascular Disease Prevention Guidelines into Clinical Practice: an Unmet Challenge?
Current Pharmaceutical Design Editorial: (Persistent Elevation of Blood Pressure in Children and Adolescents is Associated with Arterial Hypertension and Premature Atherosclerosis in Adults. Is it Possible to Reverse this?)
Current Vascular Pharmacology Heart Transplantation in Biventricular Congenital Heart Disease: Indications, Techniques, and Outcomes
Current Cardiology Reviews A Review on Post Pregnancy Healer Herbs
Current Women`s Health Reviews Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients
Current Vascular Pharmacology Editorial: Paving the Way for Improved Antiplatelet Therapy
Current Pharmaceutical Design Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery The Connection Between C-Reactive Protein (CRP) and Diabetic Vasculopathy. Focus on Preclinical Findings
Current Diabetes Reviews Cardiac Metabolism in Myocardial Ischemia
Current Pharmaceutical Design Disease Modifying Osteoarthritis Drugs: Facing Development Challenges and Choosing Molecular Targets
Current Drug Targets Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends
Current Vascular Pharmacology Arterial Hypertension and Kidney Circulation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Assessing Systemic Arterial Hypertension Through Echocardiography: A Review for the Clinician
Current Hypertension Reviews Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design Heart Failure in East Asia
Current Cardiology Reviews Combination of Fenofibrate with Non-Statin Drug Regimens
Current Pharmaceutical Design Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Virtual Screening on Natural Products for Discovering Active Compounds and Target Information
Current Medicinal Chemistry